TIRZEPATIDE

Clinical trials for TIRZEPATIDE explained in plain language.

Never miss a new study

Get alerted when new TIRZEPATIDE trials appear

Sign up with your email to follow new studies for TIRZEPATIDE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Can a diabetes drug help kidney transplant patients lose weight safely?

Disease control Recruiting now

This study tests a weight-loss drug called tirzepatide (brand name Spartina) in 30 obese adults who have had a kidney transplant at least a year ago. The goal is to see if the drug helps them lose weight without harming their kidney function or causing serious side effects. Parti…

Matched conditions: TIRZEPATIDE

Phase: PHASE4 • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

TIRZEPATIDE

Get alerted when new TIRZEPATIDE trials appear

Can a diabetes drug help kidney transplant patients lose weight safely?